(Q41984477)

14 October 2017

Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis (English)

1 reference

14 October 2017

3

Krzysztof Zeman

1 reference

PMC publication ID

3858655

Katarzyna Siniewicz-Luzeńczyk

14 October 2017

series ordinal

1

object named as

Katarzyna Siniewicz-Luzeńczyk

1 reference

14 October 2017

Anna Stańczyk-Przyłuska

series ordinal

2

1 reference

14 October 2017

30 October 2013

1 reference

Postępy Dermatologii i Alergologii

14 October 2017

1 reference

14 October 2017

30

1 reference

14 October 2017

5

1 reference

14 October 2017

282-285

1 reference

IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic Dermatitis

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Definition and characterization of an inhibitor for interleukin-31.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Proteomic Approach to FcepsilonRI aggregation-initiated signal transduction cascade in human mast cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Pathophysiology of pruritus in atopic dermatitis: an overview.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3858655

Correlation of IL-31 serum levels with severity of atopic dermatitis

18 August 2018

1 reference

12 December 2020

Interleukin-31: a new cytokine involved in inflammation of the skin

1 reference

12 December 2020

Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin

1 reference

12 December 2020

Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis

1 reference

12 December 2020

Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

1 reference

12 December 2020

Identifiers

DOI

10.5114/PDIA.2013.38356

1 reference

14 October 2017

1 reference

PMC publication ID

3858655

14 October 2017

PubMed publication ID

24353487

1 reference

PMC publication ID

3858655